Bellatora Inc (ECGR)

[Slojab]

Randy Hudson Monday, 01/05/15 02:46:13 PM
Re: None
Post # of 7370

ONCO SHAREHOLDER UPDATE
PUBLIC INFORMATION

Dear Shareholders,

I hope this message finds you enjoying a healthy and Happy New Year.

Oncology Med, Inc., a Colorado corporation (US.ONCO.PK) (the "Company"), is in the final stages of its long-awaited reorganization. From the date the Company's former chairman announced the Company's reorganization, to-date, the road to our repositioning has been long and arduous. There have many hurdles along the way; I congratulate the Company's former and current officers and directors for their dedicated and continuing efforts on behalf of the Company, and its successors.

May I, personally, thank you for your patience during our final stages of administrative development, which have been accomplished in order to reposition the company to effect a business combination with a bona fide company engaged in ongoing business activities.

To that extent, over the past few days, the Company's board of directors, and that of Oracle, has filed two new corporations in Colorado. The first was Oracle Nutraceuticals Company ("Oracle"), which will be the new publicly traded holding company, and, the second is ONCO Merger Sub, Inc. ("Merger Sub"), which will be a pass-through vehicle in order to effect a complete a reorganization, which will be tax-free to shareholders, in accordance with the applicable provisions of Section 368(a) of the Internal Revenue Service Code of 1986, as amended (the "Code"). Following the reorganization, which was filed with the Colorado Secretary of State's Office this morning, Oracle will survive the merger and be free from all of the debts and liabilities of the Company. (Shareholders and investors may view the Company's filings, and those of Oracle and Merger Sub by searching Colorado Secretary of State's website at: http://www.sos.state.co.us/biz/BusinessEntityCriteriaExt.do

Later today or early tomorrow, we will be filing a notification of certain corporate actions with the Financial Industry Regulatory Authority ("FINRA"), which will begin counting down the time (a) to update the Company's information on the applicable electronic intermediary quotation systems, (b) to effect the split down of the Company's issued and outstanding shares of common stock from 229,682,978 shares to approximately 60,000,000 shares, and (c) to provide OTC Markets Group, Inc. with that information that will be required to update its site to reflect the new changes. Once again, subject to FINRA's review and approval, the name of the surviving public company will be "Oracle Nutraceuticals Company". The symbol will remain unchanged, with the exception of a "D" as the fifth letter designator to notify shareholders of the reverse split. (Generally, this indicator remains on the company's security for approximately 20 days.)

As a reminder, please take notice: The record day and date for the reverse split was Friday, January 2, 2015.

I am hopeful that all of the actions by the Company and by Oracle's Board of Directors will benefit the surviving corporation's shareholders in the coming weeks, months, and years. All of the actions by the respective companies' boards of directors has been to serve the best interests of the companies' shareholders.

Should any of you have any further questions, I ask that you e-mail your questions or comments to [e-mail]. I will try to answer all of your questions at my earliest convenience.

Once again, thank you for your continued patience and, on behalf of The Hudson and Grande Organization, I hope you enjoy a joyous and prosperous New Year!

Best regards,
Randy Hudson

Disclaimer: This message is for informational purposes only. The information contained herein is not an offer to sell or a solicitation to buy securities, as defined under the rules and regulations that apply to the Securities Act of 1933, of the Company. Potential investors should carefully read all public filings that the Company has filed or will file with OTC Markets Group, Inc., the Securities and Exchange Commission, and with other reliable information services that are available to the public. Prior to making any investment, investors should always consult with a licensed financial advisor and legal professional to determine if the investment is suitable for you.

This message contains "forward-looking statements" (as such term is defined in the Private Securities Litigation Reform Act of 1995), within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements.

Forward-looking statements include any statement or graphic that may project, indicate, or imply future results, events, performance, or achievements. The forward-looking statements contained herein are based on current expectations that involve a number of risks and uncertainties. These statements can be identified by the use of forward-looking terminology such as "projects", "believes", "expect", "may", "will", "should", "intend", "plan", "could", "estimate", or "anticipate", or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy that involve risks and uncertainties. Given the risks and uncertainties relating to forward-looking statements, investors should not place undue reliance on such statements.

Investors seeking to make an investment in penny stocks, buy stocks or funds, or make a stock investment to diversify a portfolio, should carefully evaluate and review all available information about the company and its principals. Investing in the stock market based upon investment news or stock quote trends involves a high degree of risk and is not considered to be a safe investment such as investing in a money market account. Investors should consult with your financial advisor before making any decision related to a money investment.